Levocetirizin Beta (Levocetirizine Dihydrochloride)

Levocetirizine acts as a selective peripheral H1‑receptor antagonist. By blocking histamine from binding to these receptors, it prevents the cascade that leads to vasodilation, increased vascular permeability, and nerve stimulation, thereby reducing the classic signs of an allergic response without significant sedation.

The appropriate dose of Levocetirizin Beta is determined by the prescribing healthcare professional based on the patient’s age, clinical condition, renal function and other factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for levocetirizine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Levocetirizin Beta is a second‑generation antihistamine, offering effective H1‑receptor blockade with a lower incidence of sedation compared with first‑generation agents such as diphenhydramine. Its rapid onset and once‑daily dosing make it convenient, while maintaining a safety profile comparable to other modern antihistamines like cetirizine or fexofenadine.

Levocetirizin Beta should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its potency throughout the shelf life.

Levocetirizin Beta is taken orally, usually as a tablet, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious but rare adverse events include angioedema, anaphylactic reactions, severe skin eruptions such as Stevens‑Johnson syndrome, significant liver enzyme elevations, and, in very uncommon cases, cardiac arrhythmias like QT‑interval prolongation. Any signs of these conditions require immediate medical attention.

Levocetirizin Beta is contraindicated in individuals with known hypersensitivity to levocetirizine, other piperazine antihistamines, or any of the product’s excipients. Caution is also advised for patients with severe renal impairment, as dose adjustment may be necessary, and it should be avoided in those with a history of serious allergic reactions to antihistamines.